Compare Neurocrine Biosciences Inc (NBIX) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Vistra Corp — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Vistra Corp trades at $161.99 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 3.1× Neurocrine Biosciences Inc's market cap, and Vistra Corp pays a 0.58% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | VST | |
|---|---|---|
Market Cap | $17.40B | $53.27B |
Sector | Health | Technology |
52-Week High | $180.55 | $217.92 |
52-Week Low | $123.10 | $134.71 |
Enterprise Value | $16.49B | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
